Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:17
Cadrenal Therapeutics Shareholders Equity (Quarterly) : 4.092M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.092M |
| March 31, 2026 | 1.797M |
| December 31, 2025 | 2.739M |
| September 30, 2025 | 2.735M |
| June 30, 2025 | 4.299M |
| March 31, 2025 | 6.113M |
| December 31, 2024 | 7.440M |
| September 30, 2024 | 3.412M |
| June 30, 2024 | 3.992M |
| Date | Value |
|---|---|
| March 31, 2024 | 6.192M |
| December 31, 2023 | 7.692M |
| September 30, 2023 | 8.746M |
| June 30, 2023 | 3.176M |
| March 31, 2023 | 4.065M |
| December 31, 2022 | -5.551M |
| September 30, 2022 | -1.180M |
| June 30, 2022 | -0.6708M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
| Eli Lilly & Co. | 40.27B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.589M |
| Total Liabilities (Quarterly) | 1.497M |
| Current Ratio | 3.666 |